Qube Research & Technologies LTD Night Hawk Biosciences, Inc. Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$5.78 - $9.6 $722,921 - $1.2 Million	-125,073 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.67 - $12.54 $331,558 - $733,289	-58,476 Reduced 31.86%	125,073 $911,000
Q4 2020 Feb 16, 2021	BUY	$5.28 - $9.59 $969,138 - $1.76 Million	183,549 New	183,549 $984,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.